Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-23T21:24:24.689Z Has data issue: false hasContentIssue false
  • English
  • Français

Endogenous mediators of growth

Published online by Cambridge University Press:  28 February 2007

Nigel Loveridge ,
Colin Farquharson  and
Ben A. A. Scheven
Nigel Loveridge
Affiliation:
Bone Growth mid Metaholirin Unit, Rowett Research Instititte. Bucksburn, Aberdeen AH2 9SN
Colin Farquharson
Affiliation:
Bone Growth mid Metaholirin Unit, Rowett Research Instititte. Bucksburn, Aberdeen AH2 9SN
Ben A. A. Scheven
Affiliation:
Bone Growth mid Metaholirin Unit, Rowett Research Instititte. Bucksburn, Aberdeen AH2 9SN
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposium on ‘Growth’
Information
Proceedings of the Nutrition Society , Volume 49 , Issue 3 , October 1990 , pp. 443 - 450
Copyright
Copyright © The Nutrition Society 1990

References

REFERENCES

Asher, R. (1947). The dangers of going to bed. Lancet ii, 967–968.Google Scholar
Baumann, G., Amburn, K. D. & Ruchanan, T. A. (1987). The effect of circulating growth hormone-binding protein on metabolic clearance, distribution and degradation of human growth hormone. Journal of Clinical Endocrinology and Metabolism 64, 657–660.Google Scholar
Baumann, G., Amburn, K. & Shaw, M. A. (1988). The circulating growth hormone (GH)-binding protein complex: A major constituent of plasma GH in man. Endocrinology 122, 976–984.CrossRefGoogle Scholar
Baumann, G., Shaw, M. A. & Amburn, K. (1989). Regulation of plasma growth hormone-binding proteins in health and disease. Metabolism 8, 683–689.Google Scholar
Baumann, G., Stolar, M., Amburn, K., Barsano, C. P. & De Vries, B. C. (1986). A specific growth hormone binding protein in human plasma: initial characterization. Journal of Clinical Endocrinology and Metabolism 62, 134–141.Google Scholar
Baxter, R. C. & Colwell, C. T. (1987). Diurnal variation of growth hormone dependent binding protein for insulin-like growth factors in human plasma. Journal of Clinical Endocrinology and Metabolism 65, 432–440.Google Scholar
Baxter, R. C. & Martin, J. L. (1986). Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. Journal of Clinical Investigation 78, 1054–1512.Google Scholar
Bradbeer, J. N., Dunham, J., Fischer, J. A., Nagant de Deuxchaisnes, C. & Loveridge, N. (1988). The metatarsal cytochemical bioassay of parathyroid hormone: validation, specificity, and application to the study of pseudohypoparathyroidism type I. Journal of Clinical Endocrinology and Metabolism 67, 1237–1243.Google Scholar
Busby, W. H., Snyder, D. K. & Clemmons, D. K. (1988). Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. Journal of Clinical Endocrinology and Metabolism 67, 1225–1230.Google Scholar
Canalis, E., Centrella, M., Burch, W. & McCarthy, T. L. (1989). Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. Journal of Clinical Investigation 83, 60–65.Google Scholar
Clemmons, D. R., Elgin, R. G., Han, V. K. M., Casella, S. J., D'Ercole, A. J. & Van Wyk, J. J. (1986). Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C/insulin-like growth factor. Journal of Clinical Investigation 77, 1548–1556.Google Scholar
Cohen, K. L. & Nissley, S. P. (1976). The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta Endocrinologica 83, 243–258.Google ScholarPubMed
Cornell, H. J., Enberg, G. & Herington, A. C. (1987). Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier bound complexed in serum. Biochemical Journal 241, 745–750.CrossRefGoogle ScholarPubMed
D'Ercole, A. J., Stiles, A. D. & Underwood, L. E. (1984). Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proceedings of the National Academy of Sciences, USA 81, 935–939.CrossRefGoogle ScholarPubMed
Dickson, I. R. & Scheven, B. A. A. (1989). Regulation of new osteoclast formation by a bone cell-derived macromolecular factor. Biochemical and Biophysical Research Communications 159, 1383–1390.CrossRefGoogle ScholarPubMed
Drop, S. L. S., Kortleve, D. J. & Guyda, H. J. (1984). Isolation of a somatomedin binding protein from preterm amniotic fluid: developmcnt of a radioimmunoassay. Journal of Clinical Endocrinology and Metabolism 59, 899–07.CrossRefGoogle Scholar
Drop, S. L. S., Valiquette, G., Guyda, H. J., Conrol, M. T. & Posner, B. I. (1979). Partial purification and characterisation of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possiblc inhibitor of insulin-like activity. Acta Endocrinoligica (Copenhagen) 90, 505–518.Google Scholar
Elgin, R. G., Busby, W. H. & Clemmons, D. R. (1987). An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I. Proceedings of the National Academy of Sciences, USA 84, 3254–3258.CrossRefGoogle ScholarPubMed
Gospodarowicz, D., Ferrara, N., Schwegerer, L. & Nuefeld, G. (1987). Structural characterization and biological functions of fibroblast growth factor. Endocrine Reviews 8, 95–114.CrossRefGoogle ScholarPubMed
Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E. & Klagsburn, M. (1986). Growth factors in bone matrix. Isolation of multiple types by affinity chromatography. Journal of Biological Chemistry 261, 12665–12674.Google Scholar
Herington, A. C., Ymer, S. & Stevenson, J. (1986). Identification and characterisation of specific binding proteins for growth hormone in normal sera. Journal of Clinical Investigation 77, 1817–1823.Google Scholar
Hodgkinson, S. C., Davis, S. T., Burleigh, B. D., Henderson, H. V. & Gluckman, P. D. (1987). Metabolic clcarance of protein bound and free insulin-like growth factor-1 in fed and starved sheep. Journal of Endocrinology 115, 233–240.Google Scholar
Holly, J. M. P. & Wass, J. A. H. (1989). Insulin-like growth factors: autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. Journal of Endocrinology 122, 611–618.CrossRefGoogle ScholarPubMed
Hui, S. L., Epstein, S. & Johnston, C. C. Jr (1985). A prospective study of bone mass in patients with type I diabetes. Journal of Clinical Endocrinology and Metabolism 60, 74–79.CrossRefGoogle ScholarPubMed
Isaksson, O. G. P., Jansson, J.-O. & Gausev, I. A. M. (1982). Growth hormone stimulates longitudinal bone growth directly. Science 216, 1237–1239.Google Scholar
Isaksson, O. G. P., Lindahl, A., Nilsson, A. & Isgaard, J. (1987). Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocrine Reviews 8, 426–438.Google Scholar
Isgaard, J., Nilsson, A., Lindahl, A., Jansson, J.-O. & Isaksson, O. G. P. (1986). Effects of local administration of GH and IGF-I on longitudinal bone growth in rats. American Journal of Physiology 250, E367–E372.Google Scholar
Jansen, M., Van Schaik, F. M. A., Ricker, A. T., Bullock, G., Woods, D. E., Gabbay, K. H., Nussbaum, A. L., Sussenbach, J. S. & Van Den Brande, J. L. (1983). Sequence of a cDNA encoding human insulin-like growth factor I precursor. Nature 306, 609–611.Google Scholar
Jansen, M., Van Schaik, F. M. A., Von Tol, H., Van Den Brande, J. L. & Sussenbach, J. S. (1985). Nucleotide sequence of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Letrers 179, 243–246.Google Scholar
Kember, N. F. (1918). Cell kinetics and the control of growth in long bones. Cell and Tissue Kinetics 11, 477–485.Google Scholar
Knauer, D. J. & Smith, G. L. (1980). Inhibition of biological activity of multiplication stimulating activity by binding to its carrier protein. Proceedings of the National Academy of Sciences, USA 77, 7252–7256.Google Scholar
Krolner, B. & Toft, B. (1983). Vertebral bone loss: unheeded side effect of therapeutic bed rest. Clinical Science 64, 537–540.CrossRefGoogle ScholarPubMed
Lanyon, L. E. (1984). Functional strain as a determinant for bone remodelling. Calcified Tissue International 36, S56–S61.Google Scholar
Linkhart, T. A. & Mohan, S. (1989). Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125, 1484–1491.Google Scholar
Loveridge, N. & Farquharson, C. (1989). A novel approach to the assay of the skeletal activities of growth factors and calciotropic hormones. Journal of Bone and Mineral Research 4, S286 Abstr.Google Scholar
Martin, J. L. & Baxter, R. C. (1986). Insulin-like growth factor-binding protein from human plasma. Journl of Biological Chemistry 261, 8754–8760.Google Scholar
Mohan, S., Jennings, J. C., Linkhart, T. A. & Baylink, D. J. (1988). Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochimica et Biophysica Acta 966, 44–55.CrossRefGoogle ScholarPubMed
Nilsson, A., Isgaard, J., Lindahl, A., Peterson, L. & Isaksson, O. G. P. (1987). Effects of unilateral arterial infusion of GH and IGF-I on tibia1 longitudinal bone growth in hypophysectomized rats. Calcified Tissue International 40, 91–96.Google Scholar
Orreffo, R. O. C., Mundy, G. R., Seyedin, S. M. & Bonewald, L. F. (1989). Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochemical and Biophysical Research Communications 158, 817–823.Google Scholar
Parsons, J. A., Rafferty, B., Gray, D., Reit, B., Zanelli, J. M., Keutman, H. T., Tregear, G. W., Callahan, E. N. & Potts, J. T. Jr (1975). Pharmacology of parathyroid hormone and some of its fragments and analogues. In Calcium Regulating Hormones, pp. 33–39 [Talmage, R. V., Owen, M. and Parsons, J. A., editors]. Amsterdam: Excerpta Medica.Google Scholar
Pead, M. J., Suswillo, R., Skerry, T. M., Vedi, S. & Lanyon, L. E. (1988). Increased 3H uridine levels in osteocytes following a single short period of dynamic bone loading in vivo. Calcified Tissue International 43, 92–96.CrossRefGoogle ScholarPubMed
Pfeilschifter, J., D'Souza, S. M. & Mundy, G. R. (1987). Effects of transforming growth factor-β on osteoblastic osteosarcoma cells. Endocrinology 121, 212–218.Google Scholar
Pfeilschifter, J. & Mundy, G. R. (1987). Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones. Proreedings of the National Academy of Sciences. USA 84, 2024–2028.Google Scholar
Pfeilschifter, J., Seyedin, S. M. & Mundy, G. R. (1988). Transforming growth factor beta inhibits bone resorption in fetal long bone cultures. Journal of Clinical Investigation 82, 680–685.Google Scholar
Povoa, G., Enberg, G., Jornvall, H. & Hall, K. (1984). Isolation and characterization of a somatomedin-binding protein from mid-term amniotic fluid. European Journal of Biochemistry 144, 199–204.Google Scholar
Reddi, A. H. & Anderson, W. A. (1976). Collagenous bone matrix-induced endochondral ossification and haemopoiesis. Journal of Cell Biology 69, 557–572.Google Scholar
Rinderknecht, E. & Humbel, R. E. (1978 a). The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. Journal of Biological Chemistry 253, 2769–2776.Google Scholar
Rinderknecht, E. R., Humbel, R. E. (1978 b). Primary structure of insulin-like growth factor II. FEBS Letters 89, 283–286.CrossRefGoogle ScholarPubMed
Robertson, W. R., Lambert, A. & Loveridge, N. (1987). The role of modern bioassays in clinical endocrinology. Clinical Endocrinology 27, 259–278.Google Scholar
Rodan, G. A. & Martin, T. J. (1981). Role of osteoblasts in hormonal control of bone resorption. Calcified Tissue International 331, 349–351.CrossRefGoogle Scholar
Russell, S. M. & Spencer, E. M. (1985). Local injections of human or rat growth hormone or of purified human somatomedin C stimulate unilateral tibia1 epiphyseal growth in hypophysectomized rats, Endocrinology 116, 2563–2567.Google ScholarPubMed
Salmon, W. D. Jr & Daughaday, W. H. (1957). A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. Journal of Laboratory and Clinical Medicine 49, 825–836.Google Scholar
Scheven, R. A. A., Hamilton, N. J., Duncan, A. & Robins, S. P. (1989). Osteoclast growth factors produced by fetal rat bone in vitro. Journal of Bone and Mineral Research 4, S285 Abstr.Google Scholar
Schlecter, N. L., Russell, S. M., Spencer, E. M. & Nicoll, C. S. (1986). Evidence to suggest that the direct growth promoting effects of growth hormone on cartilage in vivo are mediated by the local production of somatomedin. Proceedings of the National Academy of Sciences. USA 83, 7932–7934.Google Scholar
Schoenle, E., Zapf, J., Humbel, R. E. & Froesch, E. R. (1982). Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296, 252–253.CrossRefGoogle ScholarPubMed
Sissons, H. A. (1961). The growth of bone. In The Biochemistry and Physiology of Bone. pp. 443–474 [Bourne, G. H., editor]. New York: Academic Press.Google Scholar
Skerry, T., Bitensky, L., Chayen, J. & Lanyon, L. E. (1988). Load-related reorientation of bone proteoglycan in vivo. Strain memory in bone tissue. Journal of Orthopaedic Research 6, 547–551.Google Scholar
Skottner, A., Clark, R. G., Robinson, I. C. A. F. & Fryklund, L. (1987). Recombinant human insulin-like growth factor: testing the somatomedin hypothesis in hypophysectomized rats. Journal of Endocrinology 112, 123–132.Google Scholar
Sporn, M. B., Roberts, A. B., Wakelield, L. M. & de Crombrugghe, B. (1987). Some recent advances in the chemistry and biology of transforming growth factor-beta. Journal of Cell Biohgy 105, 1039–1045.Google Scholar
Sukkari, A. M., Koivisro, V. A., Rutanen, E. M., Jarvinen, H., Karonen, S. L. & Seppala, M. (1988). Insulin regulates serum levels of low molecular weight insulin-like growth factor binding protein. Journal of Clinical Endocrinology and Metabolism 66, 266–272.Google Scholar
Tashjian, A. H., Vockel, E. F., Lazzaro, M., Singer, F. R., Roberts, A. B., Derynck, R., Winkler, M. E. & Levine, L. (1985). α and β human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proceeding, of the National Academy of Sciences, USA 82, 4535–4538.CrossRefGoogle ScholarPubMed
Underwood, I. E., D'Ercole, A. J., Clemmons, D. R. & Van Wyk, J. J. (1986). Paracrine functions of somatomedins. In Clinics in Endocrinology and Metabolism: Paracrine Control, vol. 15. pp. 50–77 [Franchimont, P., editor]. London: W. B. Saunders Co.Google Scholar
Urist, M. (1965). Bone formation by autoinduction. Science 150, 893–899.Google Scholar
Zapf, J., Schocnle, E., Jagers, E., Sand, I. & Froesch, E. R. (1979). Inhibition of the action of non-Suppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. Journal of Clinical Investigation 63, 1077–1084.CrossRefGoogle ScholarPubMed